Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 26.99
BGN 2429.24BGN 26.99
BGN 323.73
60 tablet
Free AirMail shipping Hot
BGN 28.79
BGN 1727.43BGN 28.79
BGN 107.88
30 tablet
Free AirMail shipping Hot
BGN 30.59
BGN 917.66BGN 30.59
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 32.39
BGN 2915.10BGN 32.39
BGN 161.78
60 tablet
Free AirMail shipping Hot
BGN 33.29
BGN 1997.36BGN 33.29
BGN 53.90
30 tablet
Free AirMail shipping Hot
BGN 34.19
BGN 1025.63BGN 34.19
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 38.69
BGN 3481.94BGN 38.69
BGN 161.78
60 tablet
Free AirMail shipping Hot
BGN 39.59
BGN 2375.25BGN 39.59
BGN 53.90
30 tablet
Free AirMail shipping Hot
BGN 40.49
BGN 1214.57BGN 40.49
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.